SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-07-002238
Filing Date
2007-03-28
Accepted
2007-03-28 16:24:37
Documents
11
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2176852z10-k.htm 10-K 1207921
2 EXHIBIT 10.27 a2176852zex-10_27.htm EX-10.27 4252
3 EXHIBIT 21.1 a2176852zex-21_1.htm EX-21.1 1351
4 EXHIBIT 31.1 a2176852zex-31_1.htm EX-31.1 5780
5 EXHIBIT 31.2 a2176852zex-31_2.htm EX-31.2 5825
6 EXHIBIT 32.1 a2176852zex-32_1.htm EX-32.1 3475
7 G760489.JPG g760489.jpg GRAPHIC 23597
8 G142183.JPG g142183.jpg GRAPHIC 24274
9 G83378.JPG g83378.jpg GRAPHIC 21469
10 G321547.JPG g321547.jpg GRAPHIC 18761
11 G228636.JPG g228636.jpg GRAPHIC 16369
  Complete submission text file 0001047469-07-002238.txt   1374480
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000
Type: 10-K | Act: 34 | File No.: 001-33277 | Film No.: 07724537
SIC: 2834 Pharmaceutical Preparations